These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16203758)

  • 1. Updated methods for reporting clinical trials.
    Hait WN
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6753-4. PubMed ID: 16203758
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic reviews of trials and other studies.
    Sutton AJ; Abrams KR; Jones DR; Sheldon TA; Song F
    Health Technol Assess; 1998; 2(19):1-276. PubMed ID: 10347832
    [No Abstract]   [Full Text] [Related]  

  • 3. Bayesian interim analysis in clinical trials.
    Zhang X; Cutter G
    Contemp Clin Trials; 2008 Sep; 29(5):751-5. PubMed ID: 18589003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trend toward noninferiority trials may mean more difficult interpretation of trial results.
    Tuma RS
    J Natl Cancer Inst; 2007 Dec; 99(23):1746-8. PubMed ID: 18042926
    [No Abstract]   [Full Text] [Related]  

  • 5. Gatekeeping procedures with clinical trial applications.
    Dmitrienko A; Tamhane AC
    Pharm Stat; 2007; 6(3):171-80. PubMed ID: 17583553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to deal with multiple endpoints in clinical trials.
    Neuhäuser M
    Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A note on special articles on adaptive clinical trial designs.
    Chow SC
    J Biopharm Stat; 2010 Nov; 20(6):1088-9. PubMed ID: 21058103
    [No Abstract]   [Full Text] [Related]  

  • 8. Statistics review 9: one-way analysis of variance.
    Bewick V; Cheek L; Ball J
    Crit Care; 2004 Apr; 8(2):130-6. PubMed ID: 15025774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partition testing in dose-response studies with multiple endpoints.
    Liu Y; Hsu J; Ruberg S
    Pharm Stat; 2007; 6(3):181-92. PubMed ID: 17654696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Adaptive designs: appealing in development of therapeutics, and where do controversies lie?
    Wang SJ
    J Biopharm Stat; 2010 Nov; 20(6):1083-7. PubMed ID: 21058102
    [No Abstract]   [Full Text] [Related]  

  • 11. Can we obtain credible estimates of the causal effects of interventions from non-randomized trials (observational studies or so-called quasi-experiments)?
    Dunn G
    Crim Behav Ment Health; 2005; 15(2):123-5. PubMed ID: 16470507
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using disease progression models as a tool to detect drug effect.
    Mould DR; Denman NG; Duffull S
    Clin Pharmacol Ther; 2007 Jul; 82(1):81-6. PubMed ID: 17507925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretation of clinical trial results.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing model diagnostics.
    Karlsson MO; Savic RM
    Clin Pharmacol Ther; 2007 Jul; 82(1):17-20. PubMed ID: 17571070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
    Dallow NS; Leonov SL; Roger JH
    Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease modifying trials in Alzheimer disease: methodological and statistical issues.
    Andrieu S; Rascol O; Lang T; Grandjean H; Vellas B
    J Nutr Health Aging; 2006; 10(2):116-7. PubMed ID: 16554944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining several ordinal measures in clinical studies.
    Wittkowski KM; Lee E; Nussbaum R; Chamian FN; Krueger JG
    Stat Med; 2004 May; 23(10):1579-92. PubMed ID: 15122738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for handling missing values in clinical trials.
    Little RJ
    J Rheumatol; 1999 Aug; 26(8):1654-6. PubMed ID: 10451057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.